CME Sues CFTC: Fighting Over Regulatory Labels, Protecting Roll-Over Fee Revenue
Miles Bennett
CME is suing the CFTC to reclassify Kalshi's approved bitcoin perpetual contracts from 'futures' to 'swaps' — effectively using a regulatory label to block a product that eliminates the roll, the very mechanism that generates CME's core fee income.
What is this lawsuit actually about?
CME wants a court to reclassify Kalshi's bitcoin perpetual contracts from futures to swaps.
This means → if labeled swaps, the product falls under institutional-grade regulation, raising issuance and distribution barriers so high that retail investors are effectively shut out.
In plain terms = CME is not arguing whether this product should exist. It is arguing who gets to buy it — change the label, and the retail market disappears.
The CFTC called the suit "frivolous" and said it expects the court to dismiss it.
Why do perpetual contracts make CME nervous?
Traditional futures have a fixed expiry. Holders must roll positions into the next contract before expiry, and CME collects trading and clearing fees on every roll — then sells the resulting market data as a separate business.
Perpetual contracts — contracts with no expiry date, where holders pay a periodic funding rate to maintain positions — eliminate the roll entirely.
This means → the periodic trading flow CME depends on gets cut off at the source. After regulators opened a path for regulated U.S. perpetual contracts, CME, Cboe, and ICE shares all fell — the market had already priced in the threat.
Why reclassify instead of ban outright?
CME filed for reclassification, not a blanket prohibition — and that choice is telling.
This reflects CME's own judgment that perpetual contracts cannot be killed, only slowed down by raising regulatory barriers.
In plain terms = if an outright ban were viable, CME would have taken the shorter route. Choosing to re-label the product signals it knows a ban will not hold.
What happens if the compliant channel is blocked?
CME CEO Terry Duffy has publicly argued that many retail investors do not fully understand the leverage, forced-liquidation, and funding-rate risks of perpetual contracts — a point with some merit.
But closing the compliant channel does not eliminate demand. Retail traders unable to access regulated platforms will migrate to offshore venues with less disclosure, weaker oversight, and lower protection.
This means → the more rational policy path is to set leverage caps, margin standards, and forced-liquidation transparency requirements for perpetual contracts — not to push them outside the regulated system via a label change.
Where is the real boundary?
This dispute starts with bitcoin perpetual contracts, but the implications extend well beyond crypto.
If perpetual contracts gain a foothold inside the regulatory framework, equity, index, and ETF perpetuals are the next frontier.
This reflects CME's deeper fear: not one bitcoin product, but the possibility that the entire expiry-and-roll business model gets displaced by a perpetual structure.
Content is for reference only, not financial advice.